Acetamide, N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]- manufacturers
- JNJ-40929837
-
- $2380.00
-
2026-05-11
- CAS:1191044-42-4
- Purity:
- Supply Ability: 10g
|
| | Acetamide, N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]- Basic information |
| | Acetamide, N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]- Chemical Properties |
| density | 1.34±0.1 g/cm3(Predicted) | | pka | 15.88±0.20(Predicted) |
| | Acetamide, N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]- Usage And Synthesis |
| Uses | JNJ-40929837 is a selective and orally active LTA4H (leukotriene A4 hydrolase) inhibitor. JNJ-40929837 effectively inhibits aminopeptidase activity and causes serum accumulation of Pro-Gly-Pro. JNJ-40929837 can be used in asthma research[1]. | | References | [1] Low CM, et al. The development of novel LTA4H modulators to selectively target LTB4 generation. Sci Rep. 2017 Mar 17;7:44449. DOI:10.1038/srep44449 |
| | Acetamide, N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]- Preparation Products And Raw materials |
|